Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Traditional GLP-1 weight-loss treatments (such as Saxenda , Ozempic , or Mounjaro ) are typically approved for people with a BMI over 30, or over 27 with medical conditions such as diabetes or high blood pressure
Hashimoto's is not listed as a contraindication for semaglutide, tirzepatide, or any other approved GLP-1 receptor agonist
PLoS One 14(7):e0218919
When surgeons intentionally delineate and steer clear of known nerve trajectories, patients experience fewer long-term sensory issues
if a skilled-nursing rehab unit is needed, expect closer to 45 weeks before stepping down to outpatient or home therapy several times a week
Patients should contact their healthcare provider if they experience: Persistent vomiting lasting more than 24 hours or inability to keep down fluids, which raises concern for dehydration Signs of dehydration including decreased urination, dark urine, dizziness upon standing, extreme thirst, or dry mouth Severe abdominal pain , particularly if constant and radiating to the back, which may indicate pancreatitisa rare but serious adverse effect Hypoglycemia symptoms including sweating, tremor, palpitations, confusion, dizziness, or irritabilityespecially in patients taking concurrent insulin or sulfonylureas Right upper quadrant pain, fever, or jaundice which may indicate gallbladder disease, a reported adverse effect with tirzepatide [11] [12] Symptoms interfering with daily activities or causing significant distress despite conservative management Immediate emergency care is warranted for: Severe, unrelenting abdominal pain with vomiting Signs of acute pancreatitis (severe epigastric pain radiating to the back, fever, rapid pulse) Symptoms of severe dehydration or electrolyte imbalance (confusion, irregular heartbeat, muscle weakness) Suspected hypoglycemia with altered consciousness The FDA prescribing information specifically warns about the risk of acute kidney injury secondary to dehydration from gastrointestinal adverse effects
